Cited 0 time in
Efficacy and safety of canagliflozin in patients with type 2 diabetes mellitus who were, or were not, on antihyperglycaemic agents at screening
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | 김경아 | - |
| dc.date.accessioned | 2024-10-30T15:43:54Z | - |
| dc.date.available | 2024-10-30T15:43:54Z | - |
| dc.date.issued | 2014-09-15 | - |
| dc.identifier.uri | https://scholarworks.dongguk.edu/handle/sw.dongguk/50634 | - |
| dc.title | Efficacy and safety of canagliflozin in patients with type 2 diabetes mellitus who were, or were not, on antihyperglycaemic agents at screening | - |
| dc.type | Conference | - |
| dc.citation.startPage | 347 | - |
| dc.citation.endPage | 347 | - |
| dc.citation.conferenceName | 50th EASD Annual Meeting of the European Association for the Study of Diabetes | - |
| dc.citation.conferencePlace | 오스트리아 | - |
| dc.citation.conferencePlace | eed Messe Vienna Messeplatz | - |
| dc.citation.conferenceDate | 2014-09-15 ~ 2014-09-19 | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
30, Pildong-ro 1-gil, Jung-gu, Seoul, 04620, Republic of Korea+82-2-2260-3114
Copyright(c) 2023 DONGGUK UNIVERSITY. ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.
